Skip to main content
All lobbying filings

DAIICHI SANKYO, INC.

Lobbying for DAIICHI SANKYO INC

 Filing 4th Quarter - Report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Expenses
$90,000.00
What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 3
  • HOUSE OF REPRESENTATIVES
  • SENATE
  • Treasury, Dept of

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 2
  • HR 946
    ORPHAN Cures Act
  • HR 2319
    Women and Lung Cancer Research and Preventive Services Act of 2025
 Lobbying activity 2
Health Issues

Discussions regarding H.R.946, the ORPHAN Cures Act Discussions related to H.R.2319, the Women and Lung Cancer Research and Preventative Services Act Discussions related to the Protecting Patient Access to Cancer and Complex Therapies Act reintroduction

Taxation/Internal Revenue Code

Discussions regarding tax reform and tariffs

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem